Product Liability Archive » May, 2008

Product Liability - May, 2008

120 articles

• Merck, Fosamax Plaintiffs Clash Over Discovery
• FDA Wants To Reclassify Digital Mammograms
• Vioxx Deal Holds Up Even After Appeals Wins: Experts
• Judge Spurns Class Bid In W.R. Grace Case
• Con Edison Blasts City Over Steam Pipe Accident
• Courts Not Warming To Climate Change Torts
• FDA Seeks To Amend Drugs' Pregnancy Labeling
• Two Courts Overturn Vioxx Rulings Against Merck
• EU Fights WTO Ruling On Hormone-Treated Meat
• Florida Court Revives Thousands Of Asbestos Suits
• Shell, Army To Pay $35M To Clean Up Superfund Site
• Judge OKs Cleanup Deal Over Asarco's Arizona Plant
• Wyeth Makes Its Case For Preemption To High Court
• DLA Piper's Schulman Joins Pfizer As GC
• FDA Seeks Recall Of 'Illegal' ED Drug
• McKenna Long Signs On Toxic Tort Expert
• Plaintiffs Win Partial Victory In E-Ferol Class Action
• FDA's Online Tainted Food Registry Delayed
• Thompson Hine Grabs Product Liability Crew
• N.Y. Judge Finds Dell Abused Consumers
• Judge Keeps Failure-To-Warn Claim In Baxter Suit
• FDA, Medicare Launch Drug Safety Initiative
• Consulting Firm Exits Medical Monitoring Suit
• Pet Food Parties Reach $24M Settlement Deal
• Insurer Let Off Hook In Hurricane Rita Dispute
• Medtronic's Impact On Medical Device Manufacturers
• Most ConAgra Peanut Butter Claims Survive Dismissal
• Zyprexa 3rd-Party Payers' Class Bid Draws Flak
• U.S. Ratifies Treaty On Nuclear Damages Liability
• Report Links Chantix To Seizures, Heart Trouble
• Aredia MDL Parties Select First 10 Cases For Trial
• Pfizer Using Quigley Co. To Dodge Claims: Insurer
• U.S. To Collect $1.5M On $946M Marcal Claim
• Lawmakers Ask Drug Companies To Improve Ads
• Judge Won't Allow Expert To Testify In MTBE Case
• Dow, Rockwell Hit With $900M Verdict In Nuclear Suit
• Boult Cummings Partners Leave To Forge New Firm
• Fosamax Plaintiffs Try To Force Merck's Hand
• Pfizer Still Safe From Quigley Suit, Judge Rules
• Asarco, Montana Bury Hatchet Over Toxic Site
• Merck Settles With States Over Vioxx Marketing
• Group Threatens Legal Action Over Nanotubes
• Mirapex Plaintiffs Add Punitive Damages To Claim
• Wyeth Calls For End To Discovery In Prempro MDL
• Automakers Balk At Federal-Mogul Injunction Bid
• Hospitals Have Mandamus Relief: Texas High Court
• Mix-Up Leads To Acne Medication Recall
• Companies Fined For Water Contamination In Arizona
• FDA Stresses Dangers Of Transplant Drugs
• Judge Blasts Parties For Delay In Guidant MDL
• 'No Reliance' Defense Defeats Class Certification
• Light Cigarettes Marketing Bill Heads To Senate
• Lead Paint Manufacturers Balk At $2.4B Price Tag
• Biovail To Pay $24.6M Over Cardizem Marketing
• FDA Shuts Down Unlicensed Cough Medicine Co.
• Exxon Unit Hit With $8M Verdict For Kidney Cancer
• Bayer Pulls Remaining Trasylol From U.S. Market
• A Therapy Against National Barriers
• Ford Recalls Over 600,000 Pickup Trucks
• Baker Botts Picks Up Two Cos. In MTBE MDL
• FDA Puts Immucor On Notice For Safety Violations
• Fen-Phen Lawyers' Fraud Trial Gets Under Way
• Appeals Court Overturns $7.75M Vioxx Ruling
• Kids' Respiratory Problems Surge After Katrina: CDC
• Wal-Mart To Suppliers: Crack Down On Tainted Toys
• Allstate, Texas Regulators Settle Suit For $71M
• Foam Makers To Pay $30M Over R.I. Nightclub Fire
• U.S. Gives Opinion On Qui Tam Pfizer Suit
• Atrium Withdraws Some Catheters For Heparin Fears
• Labeling Changes And FDA's Oversight Of Drug Safety
• Judge Breaks Off Hershey Suit In Delaware
• Supreme Court Denies Cert In Tobacco Antitrust Suit
• Five Partners Start Majority Women-Owned Firm
• Medical Dye Makers Face Another Liability Suit
• Leiner Settles DOJ Probe Into Drug Plant Violations
• Justice Recusals Allow Apartheid Claims To Continue
• Zyprexa Lawyers Renew Quest For Additional Fees
• Litigators Urge Clarity Over Punitive Damage Rules
• State Farm Settles With 13 Katrina Plaintiffs
• Pain Pumps: The Next Medical Device Litigation Wave?
• Poultry Producers Must Face Leukemia Claims
• Rep. Blames Owner, Regulator For Utah Mine Collapse
• No Clear Hazards In Plastic Additives: FDA, CPSC
• Bausch & Lomb Told To Turn Over Disputed Docs
• USDA Seeks To Block Broader Mad Cow Testing
• BP Plea Agreement Violates U.S. Law: Appeals Court
• Lawmakers Grill Pharma Execs Over Drug Ads
• Medtronic Yanks Heparin-Coated Cardiac Devices
• DuPont Finds Groundwater Polluted By Teflon Chemical
• Lawmakers Fight FDA's Anti-Estriol Stance
• EC To Simplify Medical Device Legislation
• Ephedra MDL Nears End With Score Of Dismissals
• Lilly Fails To Halt Maine Zyprexa Wrongful-Death Suit
• $30M Thomas Settlement Nears End Of The Track
• Oil Cos. Bail Out Of MTBE Case With $422M Check
• Oil Cos. Denied Summary Judgment In MTBE Case
• Co-Counsel Joins Outcry Over Fees In Guidant MDL
• Prescription Drug Preemption Awaits Resolution
• ACandS Plan Gets Bankruptcy Court's Nod
• Negligent Design Claims Against Taser Shot Down
• Bladder Drugs May Hasten Decline Of Aged: Study
• Toyota Recalls Thousands Of SUVs
• Schneider & Wallace Calls Guidant Fees Unfair
• Minn. Reaches $38M Deal Over Bridge Collapse
• Big Pharma To Defend Ad Practices At House Hearing
• New Study Ties Biofilms To Jaw Deterioration
• FDA Warns Stryker Again Over Quality Control
• Power Cos. Pay $25M To Montana Town Over Leaks
• Bacterial Taint Prompts Meat Recall
• Judge Denies Delaying Trial For Fen-Phen Lawyers
• FDA Takes It On The Chin In Endotec Ruling
• EPA To Crack Down On Lead Emissions, Monitoring
• Wider Fentora Use Could Encourage Abuse: FDA
• Pfizer Settling Celebrex, Bextra Claims: Report
• Oregon Court Snuffs Out Suit Against Big Tobacco
• High Court RICO Ruling To Affect Mass Torts: Experts
• Baby Bottle Makers Face $1B Consumer Action
• FDA Scolds Merck About Conditions At Pa. Plant
• Dietary Products Tainted With Chromium: FDA
• Zyprexa Securities Suit Dismissed As Time-Barred